Navigation Links
Biological Psychiatry Publishes Study Showing VYVANSE Demonstrated Significant Efficacy for Treatment of ADHD for up to 12 Hours After Administration
Date:11/29/2007

VYVANSE demonstrated significant efficacy for treatment of ADHD for up to 12 hours post dosing, based on the study's primary efficacy measure, SKAMP-D. Investigators observed a significant difference in patient behavior based upon the average of investigator ratings on the Swanson, Kotkin, Agler, M-Flynn and Pelham Rating Scale deportment (SKAMP-D) scores across eight classroom sessions held during a 12-hour treatment day between patients who received VYVANSE and patients who received Adderall XR, both compared to placebo. The SKAMP-D is a standardized, validated classroom assessment tool used for evaluating the behavioral symptoms of ADHD and higher SKAMP-D ratings reflect greater impairment.

Patients in the study taking VYVANSE also demonstrated significant improvement in math problems attempted as compared to placebo, as measured by the Permanent Product Measure of Performance (PERMP) Derived Measures. When patients were observed at the 12-hour time period, the LS mean change in PERMP math problems attempted from the first measurement was 49 for patients taking VYVANSE and 22 for patients taking Adderall XR, compared to -24 for placebo. PERMP is an age-adjusted collection of math problems that provides an objective measure of performance based on the number of attempted and completed math problems. This study was not designed as a comparative trial between active treatments.

Low Interpatient Variability Demonstrated

In this study, pharmacokinetic parameters were also measured, which found that the coefficient of variance for time to maximum drug concentration for VYVANSE and Adderall XR were 15.33 and 52.77, respectively. The coefficient of variance is a measure used to determine how much variance there is in the data, with smaller numbers indicating less variability. The coefficient of variance of maximum observed drug concentration for VYVANSE and Adderall XR were 20.34 and 43.96, respectively. The relationship between pharmacokineti
'/>"/>

SOURCE Shire plc
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Thomson Scientific Publishes The Ones to Watch - A Quarterly Review of Phase Changes in the Pharmaceutical Pipeline
2. The Lancet Publishes Major Phase 3 Study on Novel Oral Direct Thrombin Inhibitor
3. The New England Journal of Medicine Publishes First Clinical Results for MedImmunes Chitinase-like Protein YKL-40 in Patients With Asthma
4. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
5. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
6. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
7. Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma
8. Multiple Myeloma Research Consortium (MMRC) Partners with Novartis to Advance Phase II Study of Deacetylase Inhibitor
9. Potential Safety Issue Identified in Ongoing Phase 2 Clinical Study of HCV-796
10. Study Suggests High-Dose Fish Oil May Significantly Improve Behavior in Children with ADHD
11. MicroDose Announces Positive Results From the QDose Inhaled Insulin Glucose Clamp Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2014)... percent of Americans believe the abuse of strong prescription pain ... safety issue in the United States , ... & Partners, a Cincinnati based research ... the prescription medication abuse problem and the need for medical ... facing our country," Rex Repass , CEO of the ...
(Date:8/21/2014)... 21, 2014 InfinityQS International, Inc., the ... Intelligence , today announces Infusion Chicago, its 9 ... be held Oct. 9-10, 2014, at the Chicago ... showcase the necessity for implementing a quality system ... Intelligence to gain insight into production processes. Complimentary ...
(Date:8/21/2014)... -- Professional Compounding Centers of America (PCCA) will ... three best scientific presentations at the sixth ... Formulating Better Medicines for Children  conference, held ... Greece , includes dozens of poster-style scientific ... three winners will be selected by a panel ...
Breaking Medicine Technology:Consumers Desperate For Measures To Curb Prescription Drug Abuse 2Consumers Desperate For Measures To Curb Prescription Drug Abuse 3InfinityQS to Host Manufacturing Intelligence Conference in Chicago 2Professional Compounding Centers of America will award top poster-session winners at European Paediatric Formulation Initiative in Athens 2
... Food and Drug Administration today allowed marketing of the first ... dengue fever or dengue hemorrhagic fever, a leading cause of ... (Logo:   http://photos.prnewswire.com/prnh/20090824/FDALOGO ) The dengue ... infected Aedes mosquito. As many as 100 million ...
... 2011 The U.S. Food and Drug Administration today cleared ... assay that is designed to rapidly detect the toxin B ... cause of diarrhea that can lead to colitis, other serious ... http://photos.prnewswire.com/prnh/20090824/FDALOGO ) Clostridium difficile ( ...
Cached Medicine Technology:FDA Permits Marketing of First Test to Help Diagnose Dengue Fever 2FDA Permits Marketing of First Test to Help Diagnose Dengue Fever 3FDA Clears Test for Bacteria That Can Cause Serious Intestinal Disease 2
(Date:8/21/2014)... by T-type calcium channels in the thalamic reticular ... calcium. These channels enable thalamic reticular nucleus neurons ... enter a hyper-excited state. , In order to ... seizures, the researchers conducted an experiment to induce ... to delete the T-type calcium channel CaV3.3. The ...
(Date:8/21/2014)... August 21, 2014 ... Peripheral Vascular Devices Market by Angioplasty ... Catheter (IVUS, OCT), IVC Filter (Retrievable), ... 2018" analyzes and studies the major ... the U.S. and Canada. , Browse ...
(Date:8/21/2014)... 21, 2014 mynt welcomes industry leaders ... to join its growing company. Since its pre-launch in ... product sales and continues to gain momentum leading up ... Rob and Tiffanie came into network marketing by chance. ... number of network marketing companies. Tiffanie needed help at ...
(Date:8/21/2014)... 21, 2014 One of the emerging trends ... ostomy drainage bags. This increases the availability and accessibility of ... forecast the Global Ostomy Care Accessories market to ... 2013-2018. According to the report, the Global Ostomy Care Accessories ... is one of the major drivers. The number of procedures ...
(Date:8/21/2014)... Raleigh, NC (PRWEB) August 21, 2014 ... proteins produced by Staph bacteria has been used to ... just posted an article on the new research. ... at the University of Western Australia treated mesothelioma ... that it killed the cancer cells while simultaneously stimulating ...
Breaking Medicine News(10 mins):Health News:North American Interventional Cardiology and Peripheral Vascular Devices Market worth $5.9 Billion by 2018 - Research Report by MarketsandMarkets 2Health News:North American Interventional Cardiology and Peripheral Vascular Devices Market worth $5.9 Billion by 2018 - Research Report by MarketsandMarkets 3Health News:North American Interventional Cardiology and Peripheral Vascular Devices Market worth $5.9 Billion by 2018 - Research Report by MarketsandMarkets 4Health News:North American Interventional Cardiology and Peripheral Vascular Devices Market worth $5.9 Billion by 2018 - Research Report by MarketsandMarkets 5Health News:Industry Leaders Rob and Tiffanie Moffitt Join mynt 2Health News:Ostomy Care Accessories Market 2014 – 2018 Global Forecasts and Analysis in New Research Report at Sandlerresearch.org 2Health News:Ostomy Care Accessories Market 2014 – 2018 Global Forecasts and Analysis in New Research Report at Sandlerresearch.org 3Health News:Ostomy Care Accessories Market 2014 – 2018 Global Forecasts and Analysis in New Research Report at Sandlerresearch.org 4Health News:Study Finds Bacteria Compound Shrinks Mesothelioma Tumors, According to Surviving Mesothelioma 2
... , , DALLAS ... PHNS Inc. announced its,new "24/7 Claims Acceleration" services for U.S. ... and China -based IT and business,process outsourcing provider iSoftStone. ... in Tianjin, China . All of this,new team have ...
... Ariz. , Feb. 9 Cancer Clinics of ... oncologists has announced the addition of The West Clinic, ... http://www.newscom.com/cgi-bin/prnh/20080612/AQTH094LOGO ) , "CCE is very pleased to welcome The ... Pennsylvania Oncology, Philadelphia, PA and Chairman of CCE. ...
... , KNOXVILLE, Tenn. , Feb. 9 Team ... the largest suppliers of outsourced healthcare professional staffing and administrative services ... , today announced results for its fourth quarter and full fiscal ... be a landmark quarter for TeamHealth, and we are pleased to ...
... , BOCA RATON, Fla. , Feb. 9 ... and Prevention, nearly one in four women in the United ... or boyfriend at some point in her life. Another startling statistic ... in 5 Canadian teens experience dating violence. , (Photo:   http://www.newscom.com/cgi-bin/prnh/20100209/LA52551 ...
... , Feb. 9 International Planned Parenthood ... and Young People in the 21st Century," advocates policies ... of parents and the moral values of our society, ...  ) , The report promotes contraceptive sex education ...
... STATESVILLE, N.C. , Feb. 9 Jimmy Johnson ... excellence! No, not the four-time Sprint Cup champion Jimmie Johnson, ... host. , The newly named ExtenZe spokesman and star of the ... Speedway on Sunday, Feb. 14 , the day of the Daytona ...
Cached Medicine News:Health News:PHNS Implements New Accelerated Claims Resolution Services With iSoftStone 2Health News:PHNS Implements New Accelerated Claims Resolution Services With iSoftStone 3Health News:PHNS Implements New Accelerated Claims Resolution Services With iSoftStone 4Health News:The West Clinic Joins Cancer Clinics of Excellence (CCE) 2Health News:Team Health Holdings, Inc., Announces Fourth Quarter and Fiscal 2009 Financial Results 2Health News:Team Health Holdings, Inc., Announces Fourth Quarter and Fiscal 2009 Financial Results 3Health News:Team Health Holdings, Inc., Announces Fourth Quarter and Fiscal 2009 Financial Results 4Health News:Team Health Holdings, Inc., Announces Fourth Quarter and Fiscal 2009 Financial Results 5Health News:Team Health Holdings, Inc., Announces Fourth Quarter and Fiscal 2009 Financial Results 6Health News:Team Health Holdings, Inc., Announces Fourth Quarter and Fiscal 2009 Financial Results 7Health News:Team Health Holdings, Inc., Announces Fourth Quarter and Fiscal 2009 Financial Results 8Health News:Team Health Holdings, Inc., Announces Fourth Quarter and Fiscal 2009 Financial Results 9Health News:Team Health Holdings, Inc., Announces Fourth Quarter and Fiscal 2009 Financial Results 10Health News:Team Health Holdings, Inc., Announces Fourth Quarter and Fiscal 2009 Financial Results 11Health News:Team Health Holdings, Inc., Announces Fourth Quarter and Fiscal 2009 Financial Results 12Health News:Team Health Holdings, Inc., Announces Fourth Quarter and Fiscal 2009 Financial Results 13Health News:Team Health Holdings, Inc., Announces Fourth Quarter and Fiscal 2009 Financial Results 14Health News:Team Health Holdings, Inc., Announces Fourth Quarter and Fiscal 2009 Financial Results 15Health News:Team Health Holdings, Inc., Announces Fourth Quarter and Fiscal 2009 Financial Results 16Health News:Team Health Holdings, Inc., Announces Fourth Quarter and Fiscal 2009 Financial Results 17Health News:Team Health Holdings, Inc., Announces Fourth Quarter and Fiscal 2009 Financial Results 18Health News:Team Health Holdings, Inc., Announces Fourth Quarter and Fiscal 2009 Financial Results 19Health News:Team Health Holdings, Inc., Announces Fourth Quarter and Fiscal 2009 Financial Results 20Health News:Team Health Holdings, Inc., Announces Fourth Quarter and Fiscal 2009 Financial Results 21Health News:Team Health Holdings, Inc., Announces Fourth Quarter and Fiscal 2009 Financial Results 22Health News:Team Health Holdings, Inc., Announces Fourth Quarter and Fiscal 2009 Financial Results 23Health News:ADT Safety Tips: Personal Safety 2Health News:ADT Safety Tips: Personal Safety 3Health News:ADT Safety Tips: Personal Safety 4Health News:Family Research Council: Planned Parenthood Report Oversexualizes Ten-Year-Olds, Undermines Parental Authority 2Health News:Jimmy Johnson Will Step Into Role as Honorary Crew Chief for ExtenZe Racing at Daytona 2Health News:Jimmy Johnson Will Step Into Role as Honorary Crew Chief for ExtenZe Racing at Daytona 3
The Model 273 is a general purpose instrument with output that may be either DC-coupled for very slow changes such as venous occlusion and penile tumescence studies or AC-coupled for respiratory or p...
... Plastic and fabric specialty drapes ... gynecology. Steri-Drape absorbent prevention fabric ... fluid strike-through reducing the need ... Drape Pack, Op tape, Hand ...
... top design takes into account a wide ... flexible working environment for the surgical team. ... be matched exactly to your patients height. ... creates superior access for image amplification procedures. ...
... Mitek is the Market leader in soft ... Suture, DePuy Mitek has developed the latest ... open shoulder repair. ORTHOCORD Suture is as ... the market. Most importantly, ORTHOCORD Suture handles ...
Medicine Products: